Form 4: Clover Health CEO Jamie Reynoso Reports Stock Disposals for Tax Obligations
SEC Form 4 Filing
Jamie Reynoso, CEO of Clover Health, reports the disposal of Class A Common Stock to cover tax obligations related to vesting of Restricted Stock Units (RSUs).
Summary
- Jamie Reynoso, CEO of Clover Health, filed a Form 4 detailing changes in beneficial ownership.
- On June 14, 2024, 7,776 shares of Class A Common Stock were disposed of to cover tax obligations related to RSU vesting at a price of $1.09 per share.
- Following this transaction, Reynoso directly owns 2,459,453 shares of Class A Common Stock.
- On June 15, 2024, 5,378 shares of Class A Common Stock were disposed of to cover tax obligations related to RSU vesting at a price of $1.09 per share.
- Following this transaction, Reynoso directly owns 2,454,075 shares of Class A Common Stock.
- These RSUs vest quarterly, subject to continued service, with final vesting dates in March 2026 and September 2026.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing detailing stock disposals for tax purposes, which is neither particularly positive nor negative. The sentiment is neutral.
Future Outlook
The remaining RSUs will continue to vest quarterly in equal installments, subject to the Reporting Person's continued service, with final vesting dates occurring on March 14, 2026, and September 15, 2026.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The sale of shares to cover tax obligations upon vesting of RSUs is a common practice.
Comparison to Industry Standards
- Similar to other publicly traded companies, Clover Health's executives are required to disclose changes in their beneficial ownership of company stock through Form 4 filings.
- The practice of selling shares to cover tax obligations upon RSU vesting is standard across the industry, seen in companies like UnitedHealth Group (UNH) and Humana (HUM).
Stakeholder Impact
- The disposal of shares by the CEO could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
- The vesting of RSUs and subsequent tax obligations are part of the executive compensation package, impacting the CEO's personal finances.
Key Dates
| Date | Description |
|---|---|
| 2022-03-14 | Original grant date of RSUs, 6.25% of which vested on June 14, 2024. |
| 2022-09-16 | Original grant date of RSUs, 6.25% of which vested on June 15, 2024. |
| 2024-06-14 | Disposal of 7,776 shares of Class A Common Stock for tax obligations. |
| 2024-06-15 | Disposal of 5,378 shares of Class A Common Stock for tax obligations. |
| 2024-06-18 | Date of Form 4 filing. |
| 2026-03-14 | Final vesting date for a portion of the RSUs. |
| 2026-09-15 | Final vesting date for a portion of the RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.